Centene got big. The hard part is staying local.

Before Centene had a national footprint, it had a bookkeeper. Elizabeth “Betty” Brinn worked at a Milwaukee hospital. In 1984, she founded a nonprofit Medicaid plan called Family Hospital Physician Associates. She had grown up in a children’s home, an experience Centene connects to her concern for people struggling to obtain healthcare. The original ambition was practical: get people covered.

Four decades later, that idea sits inside a public company with $194.8 billion in annual revenue. The distance between those two facts is the interesting part. How do you become enormous while remaining useful to someone whose next problem might be finding a doctor?

The name on the card

Centene’s work becomes clearer when you separate three doors. Medicaid plans serve eligible populations under state contracts. Ambetter Health sells individual and family Marketplace coverage. Wellcare provides Medicare coverage, including Medicare Advantage and standalone prescription drug plans. Each door has different eligibility rules, payment arrangements and benefits.

For members, the useful product is a route into care: participating doctors, covered prescriptions, claims administration and help managing complicated needs. Centene also offers long-term services and supports and programs for children in foster care. For governments, the purchase is an organization capable of coordinating coverage for large, often medically complex populations.

The insurer collects premiums and pays for covered services. Under risk-bearing contracts, it carries the financial consequences when care costs more than expected. That makes its expertise unusually specific: state procurement, provider contracting, actuarial estimates, regulatory compliance and care coordination. The paperwork and the medicine share a balance sheet.

Buy reach. Keep the local knowledge.

Michael Neidorff became CEO in 1995. The company adopted the Centene name and moved to St. Louis in 1997; it went public in 2001. Acquisitions helped widen its reach. In 2019, Centene announced its WellCare purchase at an enterprise value of $17.3 billion. The transaction closed in January 2020, adding Medicare and prescription-drug capabilities.

Scale creates purchasing power and lets a company spread infrastructure costs. Local knowledge determines whether its network fits a community. Centene’s stated approach combines state-based plans and teams with national resources. Its operating argument is that familiarity with local providers and members can travel across Medicaid, Marketplace and Medicare products.

This is a competitive field. Molina, Elevance, UnitedHealthcare and CVS Health’s Aetna all pursue Medicaid business. Humana is another substantial Medicare alternative. Centene’s distinctive emphasis is its long experience with lower-income and complex populations. It also favors provider partnerships; its annual filing says owning providers is an exception.

The forecast blinked first

In July 2025, new evidence disrupted the arithmetic. Centene received industry Marketplace data from actuarial firm Wakely covering 22 states. Market growth was weaker, and the market’s implied illness burden higher, than its assumptions allowed. Expected risk-adjustment transfers no longer looked dependable. Centene withdrew its earnings guidance.

Risk adjustment moves money among insurers to account for differences in members’ health risks. It can change a plan’s economics even without a change in its own headcount. At the same time, Centene reported Medicaid cost pressure in behavioral health, home health and expensive drugs. The forecast failed before the organization could reprice its way out.

The full-year health benefits ratio rose from 88.3% in 2024 to 91.9% in 2025. More premium revenue was being consumed by medical costs. Revenue still grew. That is why revenue alone makes a poor report card for an insurer.

There was an accounting reckoning, too: a $6.7 billion noncash goodwill impairment in the third quarter. It reduced the recorded value of parts of the business; it was not a cash payment for that quarter’s care. Centene ultimately reported a $6.674 billion annual net loss attributable to the company.

Less friction, closer care

Sarah London, CEO since 2022, now faces the task of improving the economics while keeping coverage usable. By July 2026, Centene reported improved second-quarter results and raised its earnings outlook. That improvement included nonrecurring benefits, so a single quarter cannot settle the durability question.

“Meaningful milestones on our path to restoring profitability”

Sarah M. London / July 2026 results

The more tangible changes concern access. In October, Ambetter Health Solutions announced a Marathon Health collaboration for selected Indiana and Missouri counties. The offering connects eligible members with advanced primary care, including in-person and virtual services, for the 2027 plan year.

Centene also announced a November 2026 Gold Card program, initially for more than 160,000 qualifying providers and selected outpatient services. Provider feedback from 24 states helped shape it. The intended benefit is fewer administrative touchpoints for clinicians with strong approval and documentation records. Eligibility and regulatory requirements still apply.

Meanwhile, Ambetter’s announced 2027 plans include condition-specific coverage, such as heart failure options in North Carolina and Ohio. These details matter more to a patient than the parent company’s size. A covered cardiology visit is a benefit someone can actually use.

The useful part to copy

For another organization, the transferable lesson is to keep operating decisions close to the people affected, share infrastructure where it helps, and allow outside evidence to overturn comfortable estimates. This is an interpretation of Centene’s experience, rather than a formula the company has proved universally.

It depends on adequate rates, sound forecasts, accessible providers and contracts that survive renewal. Local knowledge cannot compensate indefinitely for coverage priced below its cost. For a prospective member, the practical task is simpler: check the exact plan’s network, drug list and out-of-pocket terms. Brinn’s original problem remains recognizable. Coverage has to work when somebody needs care.